Background Many studies have recently been conducted to assess the antidepressant
efficacy of glutamate modification in mood disorders. This is an update of a review first …

Background Adjunctive ketamine with electroconvulsive therapy (ECT) has been
investigated for treating major depressive disorder (MDD), but the findings have been …

Add-on ketamine anesthesia in electroconvulsive therapy (ECT) has been studied in
depressive patients in several clinical trials with inconclusive findings. Two most recent meta …

Electroconvulsive therapy (ECT) is one of the most effective treatments for depressive
disorder. Sub-anesthetic dose of ketamine exerts a rapid and robust antidepressive effect …

Objective The purpose of this study was to investigate the influence of electrical stimulation
transmitted through the body during electroconvulsive therapy on traditional and relatively …

Objectives: This review will discuss ECT efficacy and cognitive outcomes when using
ketamine as an ECT anaesthetic compared to other anaesthetics, taking into account …

Up to 20% of depressed patients demonstrate treatment resistance to one or more adequate
antidepressant trials, resulting in a disproportionately high burden of illness. Ketamine is a …

Background Acute hemodynamic responses to electroconvulsive therapy (ECT) may
increase the risk of cardiovascular complications in vulnerable patients. The aim of the …

US10441544B2 - Extended release pharmaceutical formulation - Google Patents
US10441544B2 - Extended release pharmaceutical formulation - Google Patents Extended …

Effects of ketamine in electroconvulsive therapy for major depressive disorder: meta-analysis of
randomised controlled trials - PMC Back to Top Skip to main content NIH NLM Logo Access …